Autism treatment: Dietary supplement OSR#1 pulled off shelves after FDA warning

Pharmacies are halting sales of OSR#1, a compound marketed as a dietary supplement to parents of children with autism, six weeks after the U.S. Food and Drug Administration called the product an unapproved new drug.

Several pharmacists told the Tribune they received an e-mail last week from Boyd Haley, president of the company that makes the product, informing them that OSR#1 would not be available after Thursday.

read more at Autism treatment: Dietary supplement OSR#1 pulled off shelves after FDA warning – chicagotribune.com.

Note: To support the site we make money on some products, product categories and services that we talk about on this website through affiliate relationships with the merchants in question. We get a small commission on sales of those products.That in no way affects our opinions of those products and services.